Sperm samples from infertile men with oligozoospermia or teratozoospermia were studied by multicolour fluorescence in-situ hybridization (FISH) using DNA probes for chromosomes 13 and 21. A total of 90 809 sperm nuclei from nine infertile men and 182 799 sperm nuclei from 18 control donors were analysed. There was a highly significant increase in the frequency of spermatozoa disomic for chromosome 13 in infertile patients (0.28%) compared to control donors (0.13%) (two-tailed Z statistic P < 0.0001) and for chromosome 21 (0.48% in infertile men versus 0.37% in controls, P < 0.0001). Also there was a significantly increased frequency of diploid spermatozoa in infertile men (0.85%) compared to control donors (0.66%) (P < 0.0001). Our previous studies on these same infertile patients demonstrated increased frequencies of sperm disomy for chromosomes 1 and XY. This suggests that infertile men, who are prime candidates for intracytoplasmic sperm injection, may be at a very small increased risk of aneuploid offspring.
Introduction
Intracytoplasmic sperm injection (ICSI) has revolutionized the treatment of male infertility in the past few years. Even men with extremely small numbers of spermatozoa with poor motility and morphology can be successful at fertilizing oocytes with this new technique. However, there is concern that these infertile men may have a higher frequency of chromosomal abnormalities in their spermatozoa and that ICSI might lead to a higher frequency of chromosomally abnormal offspring. Recent reports based on prenatal diagnosis in ICSI pregnancies have indicated an increased risk of sex chromosomal abnormalities in approximately 1% of cases (Liebaers et al., 1995) and Van Opstal et al. (1997) have shown these to be of paternal origin. In a study of five infertile men with oligozoospermia, asthenozoospermia or teratozoospermia, we demonstrated an increased frequency of numerical chromosomal abnormalities in the spermatozoa of infertile men by two different techniques: the human spermatozoa-hamster oocyte fusion system which allows analysis of human sperm karyotypes and multicolour fluorescence in-situ hybridization (FISH) analysis of chromosome-specific DNA probes (Moosani et al., 1995) . Results of over 500 sperm karyotypes demonstrated a significant increase in the frequency of total sperm chromosome abnormalities in infertile patients compared to control donors. As well as sperm karyotyping, multicolour FISH analysis was performed on these men with a minimum of 10 000 sperm nuclei analysed per chromosome probe per patient for chromosomes 1, 12, X and Y. There was a significant increase in the frequency of disomy for chromosome 1 and particularly for XY disomy in infertile patients.
This initial study on five infertile patients was expanded to ten patients (Martin, 1996) . All of the infertile men with oligo-, astheno-, or teratozoospermia had a normal peripheral blood lymphocyte karyotype, normal concentrations of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone and no known exposure to radiation, drugs or recognized environmental toxins. Multicolour FISH analysis was performed on more than 200 000 spermatozoa with a minimum of 10 000 sperm nuclei scored per male per DNA probe for each of chromosomes 1, 12, X and Y. There was a statistically significant increase in the frequency of disomy for chromosome 1 and XY disomy in infertile men compared to normal men, corroborating our original results. If a spermatozoon with disomy 1 fertilized a normal oocyte, a trisomy 1 embryo would be produced, which would likely be lost before implantation because of the lethality of this condition. However, a 24,XY spermatozoon would produce a 47,XXY embryo with Klinefelter's syndrome which is thought to have a high probability of surviving to term.
Along with the sex chromosomes, aneuploidies for chromosomes 13 and 21 are clinically significant because these trisomies can sometimes survive to term. In this report we have studied the same infertile men to determine if they have an increased risk of aneuploidy for chromosomes 13 and 21 in their spermatozoa.
Materials and methods

Infertile patients
The infertile patients in this study consisted of men who were undergoing fertility investigations after experiencing at least 1 year of infertility. These men either had low sperm counts (Ͻ20ϫ10 6 spermatozoa/ml), reduced motility (Ͻ40% motile) and/or poor morphology (Ͻ40% normal forms). The sperm profile for each patient is provided in Table I . The patients were recruited from the University of Calgary Infertility Clinic. The study was approved by the institutional ethics committee and all donors gave informed consent. For each patient, semen samples were collected after 3 days' abstinence.
Prior to any DNA analysis, a minimum of three samples was assessed to validate the original diagnosis of abnormal semen characteristics. In all of the ten men, information regarding childhood diseases, environmental exposures, substance abuse, radiation exposure and prescription drug usage was determined to attempt to reduce the possibility that external factors could account for their infertility. Each patient also had a normal endocrinology profile as determined by normal levels of follicle stimulating hormone, luteinizing hormone and testosterone. The patients were between the ages of 28-46 years, with a mean age of 32.8 years. None of the patients had any children at the time of study either naturally or through in-vitro fertilization (IVF). Through routine peripheral blood lymphocyte karyotyping, all patients were found to have a normal 46,XY karyotype with patient 3 carrying a normal variant for chromosome 15 (missing satellites).
Normal donors
Normal healthy men as determined from information regarding childhood diseases, chronic disorders, environmental exposure, substance abuse, radiation exposure and prescription drug usage were chosen. This group consisted of 18 men between the ages of 23-58 years with a mean of 35.6 years. All of the donors had normal semen profiles and 11 were of proven fertility and seven of unproven fertility (Kinakin et al., 1997) .
Fluorescence in-situ hybridization (FISH) studies
Multicolour fluorescence in-situ hybridization studies were performed as previously described by McInnes et al., (1998) . A commercial dual probe mixture containing SpectrumGreen ® labelled probe for chromosome 13 and a SpectrumOrange ® labelled probe for chromosome 21 was used (Vysis, Downers Grove, IL, USA). A minimum of 10 000 sperm nuclei per chromosome probe per male was scored. A spermatozoon was considered to be disomic when two fluorescent domains of the same colour were clearly positioned within the sperm head, comparable in brightness and size and at least one domain apart, and the other colour had only one signal. Certain populations of sperm nuclei were eliminated from scoring: overlapping nuclei where it was impossible to assign a signal to a given nucleus, disrupted nuclei with indistinct margins, very large nuclei with diffusely spread chromatin possibly due to over-decondensation, or nuclei with no signals due to failure to hybridize. The hybridization efficiency was at least 98% for all experiments. 
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Statistical analysis
Statistical analysis was performed by a two-tailed Z statistic (Rosner, 1995) .
Results
Multicolour FISH analysis was accomplished in nine of the ten original infertile patients (one was lost to follow up). Individual sperm profiles are provided in Table I . A total of 90 809 sperm nuclei was analysed in the infertile patients and 182 799 sperm nuclei in the control donors. FISH results on the individual infertile patients are presented in Table II . There was a highly significant increase in the mean frequency of spermatozoa disomic for chromosome 13 in infertile patients (0.28%) compared to control donors (0.13%)(Z ϭ 7.7, P Ͻ 0.0001, two-tailed Z statistic; Rosner, 1995) . The mean frequency of spermatozoa disomic for chromosome 21 was also significantly increased in infertile patients (0.48%) compared to control donors (0.37%)(Z ϭ 4.0, P Ͻ 0.0001, two-tailed Z statistic). Similarly, the frequency of diploid spermatozoa was significantly increased in infertile patients (0.85%) compared to control donors (0.66%)(Z ϭ 5.4, P Ͻ 0.0001, two-tailed Z statistic). As shown in Table III , disomy frequencies for chromosomes 1, 12, 13, 21, XX, YY, and XY have now been studied in these 306 035 spermatozoa from these infertile men, with significantly increased frequencies for chromosomes 1, 13, 21 and Y. 
Sperm chromosome aneuploidy in infertile men
Discussion
Results from this study have demonstrated for the first time a significant increase in the frequency of spermatozoa disomic for chromosomes 13 and 21 in infertile men. We also found a significantly increased frequency of diploid spermatozoa in these men. Previous studies on these same men have also shown an increased frequency of disomy for chromosome 1 and XY disomy. Donor age has been reported to be associated with the frequency of disomic spermatozoa, particularly for the sex chromosomes (Griffin et al., 1995; Robbins et al., 1995; Martin et al., 1995) . It is unlikely that this affected our study since the mean ages of the infertile patients (32.8 years) and control donors (35.6 years) were similar, with the control donors being older. Also we have completed a study in the 18 control donors demonstrating no paternal age effect for chromosomes 13 and 21 (McInnes et al., 1998) .
Four other studies have published results of FISH analysis on spermatozoa from infertile men. Miharu et al. (1994) studied disomy frequencies for chromosomes 1, 16, X and Y in 12 infertile men using one-colour FISH and found no significant differences compared to control donors. Guttenbach et al. (1997) investigated disomy frequencies for chromosomes 1, 7, 10, 17, X and Y in 45 infertile men using one-and twocolour FISH. They found no significant increase in patients compared to controls. In both of these studies a relatively small number of sperm nuclei was analysed per male per chromosome. Also XY disomy could not be ascertained because of the use of one-colour FISH. Lähdetie et al. (1997) studied aneuploidy in spermatozoa in 12 infertile men: eight with normal or nearly normal semen profiles and four with oligo-astheno-teratozoospermia (OAT). Two-colour FISH was used for chromosome 1 and 7 and 10 000 spermatozoa were scored per individual. Disomy frequencies for both chromosomes as well as diploidy frequencies were significantly increased in the OAT patients compared to controls. Bernardini et al. (1997) studied 15 infertile patients (six with unexplained infertility and nine OAT patients) by double target in-situ hybridization. They found that OAT patients had a significantly increased frequency of disomy for the sex chromosomes and chromosomes 1 and 17 compared to patients with unexplained infertility or control donors. Other studies, reported in abstract form, have also demonstrated a significant increase in the frequency of disomic spermatozoa in infertile patients com-2789 pared to normal donors (Pang et al., 1995; Finkelstein et al., 1995) .
Studies on infertile patients have tended to be heterogeneous and include many types of male infertility; for example, oligozoospermia, teratozoospermia, OAT patients, unexplained infertility, patients with antisperm antibodies. From the preliminary data so far, it appears that OAT patients or patients with oligozoospermia appear to have an increased risk of aneuploidy. However, further studies with clear delineation of types of infertility are required to assess this important question.
Since previous FISH studies have demonstrated an increase in the frequency of XY spermatozoa in infertile men (Moosani et al., 1995) and it has been shown that ICSI pregnancies have an increased frequency of fetuses with a sex chromosomal abnormality (Liebars et al., 1995) it has been suggested that the cause of this might be Klinefelter's syndrome mosaicism in a significant subset of the infertile males (Persson et al., 1996) leading to injection of 24,XX and 24,XY spermatozoa. This is certainly one possibility, but in 1996 we argued that a generalized pairing abnormality in the meiotic chromosomes could predispose to both non-disjunction and oligozoospermia (Martin, 1996) . Oligospermia has been associated with chromosome pairing problems within both the autosomes and the sex chromosomes. Egozcue et al. (1983) reported that in infertile males, there is an increased frequency of pairing disruptions resulting in meiotic arrest. It is possible that a pairing abnormality in these infertile males could lead to meiotic arrest in some cells causing oligozoospermia and aneuploidy in other cells capable of completing spermatogenesis. Sex chromosomes and small chromosomes are particularly susceptible to pairing abnormalities since they generally have only one crossover. Hassold et al. (1991) have determined that there is a reduction in recombination for the XY bivalent in meioses leading to the 47,XXY karyotype. Furthermore, recent evidence from this group has demonstrated altered recombination in cases of trisomy 21 of paternal origin (Savage et al., 1997) . Thus it is quite plausible that infertile men have decreased recombination and pairing leading to both meiotic arrest (oligozoospermia) and non-disjunction.
What is the clinical significance of these data? Our studies and those of others have demonstrated an increased frequency of sex chromosomal aneuploidy in spermatozoa of infertile men (particularly with oligozoospermia or OAT patients). The relative risk compared to control donors is ϫ2-3 which agrees very well with the frequency of 1% sex chromosomal abnormalities observed from prenatal diagnoses after ICSI. Our recent data for chromosomes 13 and 21, also clinically significant trisomies, show more modest relative risks of ϫ2 and ϫ1.3, respectively. Clearly these are very preliminary figures and must be replicated by other laboratories. However, the relatively smaller increase coupled with the much greater prenatal lethality of Patau syndrome and Down's syndrome might explain why these trisomies have not been detected in studies of prenatal diagnosis following ICSI. However, it would be prudent to continue monitoring ICSI pregnancies by prenatal diagnosis and to compile these data so that we can answer these important questions in the future.
